Pharmacology, Toxicology and Pharmaceutical Science
Bupivacaine
100%
Local Anesthetic Agent
35%
Parkinson's Disease
29%
Pharmacokinetics
26%
Ketamine
25%
Nicorandil
20%
Potassium Channel
19%
Disease
19%
Anesthetic Agent
17%
Clonidine
17%
Carotid Atherosclerosis
17%
Arteriosclerosis
17%
Toxic Injury
17%
Ethanol
12%
Lemakalim
11%
Scanning Electron Microscopy
10%
Acute Toxicity
10%
Table Salt
8%
Formate
8%
RNA-Sequencing
8%
Levodopa-Induced Dyskinesia
8%
Impulse Control Disorder
8%
Valerian
8%
Antihypertensive Agent
8%
Hemoglobin A1c
8%
Lidocaine
8%
Carboxyhemoglobin
8%
Prevalence
8%
Calcium Antagonist
8%
Xanthine
8%
Cancer Growth
8%
SARS Coronavirus
8%
Hydrocortisone
8%
Glycosylated Hemoglobin
8%
Infection
8%
Cholinergic Receptor Stimulating Agent
8%
Plasma Protein
8%
Randomized Controlled Trial
8%
Pharmacodynamics
8%
CYP3A
8%
Statin (Protein)
8%
Carotenoid
8%
Colorectal Carcinoma
8%
Comorbidity
8%
Bioavailability
8%
Elimination
7%
Verapamil
7%
Dopamine Receptor Stimulating Agent
6%
Pipecolic Acid
5%
Convulsant Agent
5%
Medicine and Dentistry
Parkinson's Disease
42%
Arteriosclerosis
34%
Disease
28%
Red Wine
25%
Lifestyle Modification
25%
Infection
23%
COVID-19
21%
Physical Activity
21%
Gut Microbiome
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Randomized Controlled Trial
17%
Comorbidity
15%
Blood Pressure
13%
Early Diagnosis
12%
Malignant Neoplasm
12%
Progressive Supranuclear Palsy
11%
Prevalence
11%
Mediterranean Diet
11%
Biological Marker
10%
Secretion (Process)
10%
Atypical Parkinsonism
9%
Carotid Atherosclerosis
9%
Exercise
9%
Awareness
8%
Disease Severity
8%
Arterial Pressure
8%
Household
8%
Hydrocortisone
8%
Mild Cognitive Impairment
8%
Counseling
8%
Fat Intake
8%
microRNA
8%
Drug Therapy
8%
Diet Quality
8%
Multipartite
8%
Blood Flow Velocity
8%
Biomedical Research
8%
Artery Blood Flow
8%
Metabolomics
8%
Vaccine
8%
Saturated Fatty Acid
8%
Middle Cerebral Artery
8%
Brain Blood Flow
7%
Diastolic Blood Pressure
6%
Cohort Analysis
6%
Diagnosis
6%
Statin
5%
Systolic Blood Pressure
5%
Antihypertensive Agent
5%
Immunity
5%
Neuroscience
Parkinson's Disease
85%
Locomotor Activity
34%
Circadian Rhythm
17%
L-DOPA
17%
Dyskinesia
17%
Bupivacaine
17%
Agonist
17%
Potassium Channel
17%
Statin
17%
Mild Cognitive Impairment
17%
Randomized Controlled Trial
17%
Comorbidity
13%
Progressive Supranuclear Palsy
11%
Atypical Parkinsonism
9%
MicroRNA
8%
Impulse Control Disorder
8%
Middle Cerebral Artery
8%
Cortisol
8%
Deconvolution
8%
Ketamine
8%
Dopamine Agonist
7%
Dopaminergic
5%
Cerebrovascular Disease
5%
Suprachiasmatic Nucleus
5%